Hematology

Filter

Patient and physician perspectives on shared decisions in CML

October 2025

In this new podcast episode, Lisa Machado, a patient advocate diagnosed with CML in 2008 and clinician and CML expert Jeffrey Lipton, sit…

Eytan Stein

Hema Now: Episode 11: Decoding Leukaemia's Epigenetic Drivers

Eytan Stein, Chief of the Leukaemia Service; Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA

Gender and Age Affect Bleeding Risk in Anticoagulant Treatment

Bleeding risk from anticoagulants varies by gender and age in venous thromboembolism treatment, especially during the initial phase.

Study Finds Donor Choice Influences Haploidentical Stem Cell Transplant Success

Donor age and cell dose significantly influence outcomes in haploidentical stem cell transplants, reveals new research.

Study Finds Sickle Cell Trait Not Linked to Exertion-Related Death

New research finds no evidence linking sickle cell trait to acute pain crises or sudden death during exertion.

Daratumumab-Based Quadruplet Regimen Sets New Benchmark in Myeloma Treatment

A Phase III trial shows adding daratumumab to VRd enhances treatment response in transplant-ineligible multiple myeloma patients.

Nonselective β-Blocker Use Linked to Mortality After Stem Cell Transplantation

Nonselective β-blockers may impair haematopoietic regeneration after transplantation, particularly with post-transplant chemotherapy.

Genetic Analysis of 527 Cases of Rare Bleeding Disorders: EAHAD 2025

Genetic analysis of 527 rare bleeding disorder cases reveals novel variants, according to research presented at the EAHAD 2024 Annual Congress.

Reclassification of Haemophilia Carriers Improves Diagnosis and Care: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, a new system improves diagnosis and care for hemophilia carriers.

Loading posts...

« Previous 1 … 18 19 20 21 22 … 95 Next »